Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, won a $305 million bid to acquire most of 23andMe's assets. The win overturned a prior Regeneron plan at $256 million during the company's bankruptcy auction, promising enhanced consumer privacy protections and a consumer privacy advisory board. This transaction positions Wojcicki to continue advancing genetic testing aligned with the company’s foundational health-oriented mission.